摘要
目的探讨阿斯美联合酮替芬与枇杷止咳胶囊治疗慢性咳嗽的临床疗效及不良反应。方法选择2011年5月—2012年10月该院收治的68例慢性咳嗽患者作为观察对象,随机分为试验组和对照组,每组34例,试验组口服阿斯美联合酮替芬治疗,对照组口服枇杷止咳胶囊治疗。比较治疗后两组患者咳嗽有效率及药物不良反应。结果治疗后,试验组咳嗽有效率为91.2%明显大于对照组52.9%,两组比较差异有统计学意义(P<0.05);两组不良反应发生率均为11.76%,差异无统计学意义(P>0.05)。结论阿斯美联合酮替芬治疗慢性咳嗽疗效确切,不良反应少,能够提高患者的生活质量,值得临床推广应用。
Objective To compare the clinical effect and adverse reactions between asmeton combined with ketotifen and loquat cough capsules in the treatment of chronic cough. Methods 68 chronic cough patients admitted in our hospital from May, 2011 to October, 2012 were selected as the subjects, and they were randomly divided into experimental group and control group, 34 cases in each group. The experimental group was treated with asmeton combined with ketotifen orally, and the control group was treated with oral loquat cough capsules. The cough efficiency and drug adverse reactions of two groups after treatment were compared. Results After the treatment, the cough efficiency of the experimental group was 91.2%, which was obviously higher than 52.9% of the control group, the difference was statistically significant （P〈0.05）; the incidence of adverse reactions of both groups was 11.76%, the difference was not statistically significant （P〉0.05）. Conclusion Asmeton combined with ketotifen has curative effect on chronic cough with less adverse reactions, which can improve the quality of life of patients, and is worthy of clinical application.
出处
《中外医疗》
2014年第10期32-33,共2页
China & Foreign Medical Treatment
